Clinical Trial Update: Local Consolidative Radiotherapy for Oligoprogressive in Non-small Cell Lung Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 trial evaluating local consolidative radiotherapy for oligoprogressive non-small cell lung cancer has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Wake Forest University Health Sciences | Conditions: Non Small Cell Lung Cancer, Oligoprogressive | Phase 2 | Status: WITHDRAWN